There are no announcements yet.
Over the years, evidence from research studies have suggested that cannabinoids such as CBD oil have helped in controlling seizures of patients with...EPILEPSY
Epilepsy is a neurological disorder that shows itself in the form of seizures. Seizures are the disruption of electrical activity of the brain can last from 30 seconds to two minutes. Physical signs of a seizure include uncontrolled convulsions, repeated blinking of the eyes, difficulty breathing or talking, and loss of bladder control.
Diagnosis is given if someone has two or more unprovoked seizures in the span of 24 hours. It may be caused by genetic inheritance, infections, or a change in brain structure from brain injury and affects 65 million people worldwide of all ages. 34% of sudden deaths in children are caused by Sudden Unexpected Death in Epilepsy.
Epilepsy may be characterized by a group of features to identify epilepsy syndromes. Common types of Epilepsy Syndromes include: West syndrome, Doose syndrome, Lennox-Gastaut syndrome, and Sturge-Weber syndrome.
Most epileptic patients are either prescribed long-term drug therapy that runs the risk of serious side effects, try dietary or behavioral therapies, or undergo brain surgery when medicine does not work. Medical marijuana is a potential treatment for epilepsy as research studies imply that CBD can act as an anticonvulsant and can significantly reduce seizures without psychoactive effects. Rigorous clinical trials for medical cannabis in epilepsy are continuing to run in hopes of achieving FDA approval.
Attending the GHC Summit is how I got involved with iCannabinoid. I had just finished my Masters thesis about prescription drug abuse and misuse and the rest is history.
The Company is in the process of getting a third-party, independent valuation to establish the value of its CBN patent for the Canadian, U.S.,...The Company is in the process of getting a third-party, independent valuation to establish the value of its CBN patent for the Canadian, U.S., European, and global markets for the purpose of licensing other organizations to develop and sell CBN product lines under the protection of the Company’s U.S. patent.
For full article
www.otcmarkets.com/stock/CBIS/news/story Show more